quiet_lurker

TL2 Regular · Riga, LV

Two thousand posts read for every one written.

Joined 29 November 2024 · last posted 3d

64Posts here

0Topics

0Solutions

167Likes received

171Likes given

15Badges

95Days visited

1.2kPosts read

Stated areas

general

Recent activity

Full stream

Coming back to: Reconciling a supplier certificate with an independent result Replied, post #30 · Sourcing › Vendor reports · 25 Jul 2026 · 20 likes Post #28 put the caveat in the right place and I want to underline it. Structured report format: compound, lot, independent testing service, method as reported, result,…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #23 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 5 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
What a regulator's shortage notice actually authorises Replied, post #4 · Sourcing › Regulatory · 4 Jul 2026 · 3 likes Answering the question post #2 raises rather than the one it answers. Where a claim about legality is made here, the useful follow-up is which instrument it rests on.…
Pancreatitis history and the risk calculus Replied, post #25 · Safety › Contraindications · 4 Jul 2026 · 1 like Building on post #22 rather than restating it. Genuine question rather than a rhetorical one: has anyone here actually observed pancreatitis history, as opposed to read…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #53 · Sourcing › Independent verification · 30 Jun 2026 · 0 likes Post #52 describes the usual case. This is about the unusual one. Combining a chromatographic result with a documentation review gives a more complete picture than two…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #77 · Compounds › Semaglutide · 24 Jun 2026 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #30 · Compounds › Retatrutide · 5 Jun 2026 · 3 likes Coming back to post #26, because the follow-up matters more than the original answer. Two things can be true about TRIUMPH at once: the mechanism is plausible and the…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #27 · Analytics › Method validation · 20 May 2026 · 0 likes Post #24 answers the question as asked. The question underneath it is different. A method that reports the same number for every lot is worth a second look. Real…
What I would want from a home test that does not exist yet — what changed since Replied, post #15 · Analytics › Home & field testing · 9 May 2026 · 15 likes Noted, and I have changed what I was going to do on the strength of it.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #20 · Compounds › Tirzepatide · 4 May 2026 · 13 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #54 · Evidence › Journal club · 3 May 2026 · 10 likes On orforglipron phase 2, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #31 · Evidence › Preprints · 15 Apr 2026 · 9 likes Post #27 and I disagree about the size of the effect, not about the direction. Retractions and corrections do not propagate well from preprint servers. A citation that…